Skip to content

Clinical Heritage: Success of the MRK™

Information for healthcare professionals

Clinical Heritage: Success of the MRK™

The MRK™, also manufactured by MatOrtho® (previously Finsbury), is the original 1994 ‘medial ball-and-socket knee’ and remains in popular use. The clinical success of the MRK™ has strong relevance as a ‘proof of concept’ to the expected long-term outcomes for the SAIPH® Knee, which is an evolution of the original design.

Overall, the MRK™ has been shown to provide greater inherent stability than comparator devices18,19,20. Patients with a medially stabilised knee notice the difference, and express that they prefer the design over posterior substituting (PS), cruciate retaining (CR) and mobile designs, citing feelings of stability, normality and strength on stairs as reasons for their preference21,22. With its lateralised trochlea11 the MRK™ exhibits a more normal patellar function12. It provides better restoration of ROM when compared to a standard PS knee design23 and mean ROM is equal that of a ‘high-flex’ knee24.

When compared to all other TKR designs, NJR collected patient reported outcome measures (PROMs) show that the benefits of the MRK™ are reflected in higher functional scores22,23 and improved rates of success and satisfaction when compared to other TKRs20,22. The MRK™ also provides better high-end function for categories of daily living, sport and exercise, movement and lifestyle included in the total knee function questionnaire (TKFQ). In this questionnaire, patients who received an MRK™ have scored significantly better 1 and 2 years postoperatively than counterparts who had received the most commonly used standard PS knee in the UK at the time23.

Survivorship for the MRK™ is the best of all TKR devices available: it has been reported with the LOWEST revision rate of ALL TKRs in the NJR more times than any other brand – 50% of all reporting instances since the NJR started reporting device brands in its 2009 Annual Report16,24. In the most recent 18th Annual Report (2021), the MRK™ has the lowest revision rate of all TKR brands at 17 years, the longest time point reported by the NJR, with a revision rate of 3.23% (95% CI: 2.69-3.87)17.

The MRK™ has an ODEP 15A rating for its use with and without the saddle-shaped patella25.

 

The MRK™ has the LOWEST revision rate of all TKR brands at 17 years: 3.23% (95% CI 2.69-3.87) 17 and is awarded an ODEP 15A rating25. 

The SAIPH® Knee has evolved from the original ball-and-socket device (MRK™) to incorporate all features associated with the clinical success of the concept. It is the only TKR in the world designed wholly for the medially stabilised concept without compromise, inherited or to accommodate other bearing options.

References

Resources

SAIPH® Clinical Rationale
SAIPH® Flyer
SAIPH® Operative Technique

Download Now

Fill in your details below to download the SAIPH® Clinical Rationale

Additional Text

Download Now

Fill in your details below to download the SAIPH® Flyer.

Additional Text

Download Now

Fill in your details below to download the SAIPH® Operative Technique

Additional Text

Clinical Function of the SAIPH® Knee

Normal Pattern of Movement (Knee Kinematics)

Balancing stability with freedom of movement is a principal goal of TKR design. How well a TKR achieves this can be determined by evaluating the pattern of movement in patients’ knees during well- elected activities.